Skip to content

Effect Of Haridra Churna (Haldi) in Reducing Blood Sugar in Madhumeha (Diabetes Mellitus)

A Comparative study to evaluate the Hypoglycaemic Effect of Haridra Churna and Chandraprabha Vati in Madhumeha (Type-2 Diabetes Mellitus)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023430
Enrollment
40
Registered
2020-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Haridra Churna with Pippali Churna: 40 patients will be randomly selected for this group and they will be treated with Haridra Churna in dosage of 3gm twice in a day for 21 days with â?

Sponsors

Department of Kayachikitsa Ch Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age between 40-60yrs. 2. Sex: Both male and female 3. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION. 4. FBS-126-200mg/dl PPBS-150-350mg/dl 5. HbA1c 7% and more 6. Patients taking any type of oral anti-diabetic treatment from 1. Biguanides and 2. Sulfonylurea 1. Patients with age between 40-60yrs. 2. Sex: Both male and female 3. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION. 4. FBS-126-200mg/dl PPBS-150-350mg/dl 5. HbA1c 7% and more 6. Patients taking any type of oral anti-diabetic treatment from 1. Biguanides and 2. Sulfonylurea

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 40 years and more than the age of 60 years 2. Fasting Blood Sugar Level 200 mg/dl • Post Prandial Blood Sugar Level 350 mg/dl 3. HbA1c 4. Patients depending on the insulin for blood glucose control. 5. Patients with diabetic complications. 6. Patients suffering from Secondary Diabetes. 7. Gestational diabetes. 8. Pregnant ladies and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Reduction in Prabhootmutrata (excessive urine) Reduction in Avilamutrata (Turbid urine) Reduction in Mutra Madhuryata (Sweetness in urine) Timepoint: Prabhootmutrata (excessive urine) Avilamutrata (Turbid urine) Mutra Madhuryata (Sweetness in urin) Swapnasheela (sleep) Atikshudha (Excessive hunger) Atisweda (Excessive sweating) Daurbalya (Weakness) Atitrushna (Excessive thirst) on Day 0 Day1 Day 7 Day 14 Day 21

Secondary

MeasureTime frame
Reduction in swapnasheela (sleep) Reduction in atikshudha (Excessive hunger) Reduction in atisweda (Excessive sweating) Reduction in daurbalya (Weakness) Reduction in atitrushna (Excessive thirst) Timepoint: Swapnasheela (sleep) Atikshudha (Excessive hunger) Atisweda (Excessive sweating) Daurbalya (Weakness) Atitrushna (Excessive thirst) on Day 0 Day 1 Day7 Day 14 Day221

Countries

India

Contacts

Public ContactDr Alisha

Department of Kayachikitsa, Ch. Brahm Prakash Ayurved Charak Sansthan

naimishraj@yahoo.com9560659728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026